lidocaine has been researched along with Bright Disease in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
Excerpt | Relevance | Reference |
---|---|---|
"Lidocaine was effective in 26 patients and 16 (63%) of these had their arrhythmias controlled with tocainide." | 1.26 | Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success. ( Harrison, DC; Mason, JW; Winkle, RA, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Winkle, RA | 1 |
Mason, JW | 1 |
Harrison, DC | 1 |
1 other study available for lidocaine and Bright Disease
Article | Year |
---|---|
Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
Topics: Aged; Anilides; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Humans; Lidocaine; Mal | 1980 |